IGF-1 DES

Published · Researched 2026-09-21

Overview

IGF-1 DES (DES(1-3)-IGF-1) is a truncated 67-amino-acid analog of IGF-1, missing the first three N-terminal amino acids of the native 70-aa sequence. Like LR3, it exists only as a gray-market research chemical — no pharma company makes it as an approved drug, and it is synthesized by Chinese peptide houses and sold by research-chemical vendors (Umbrella Labs, Pinnacle Peptides, Peptide Sciences legacy listings, and smaller US/EU shops). The standard retail form in 2026 is the 1 mg lyophilized vial. Its community identity is defined almost entirely in contrast to LR3 (see below).

Social standing

• Threads: thin — the track's central sweep found IGF-1 talk on Threads dominated by GLP/GH-stack content, not DES discussion.
• Forums (second layer, primary DES evidence): r/Peptides, Professional Muscle, AnabolicMinds, Evolutionary.org. The community states a consistent mechanistic distinction: DES is treated as the localized/short-acting counterpart to LR3's systemic/long-acting action. On Professional Muscle's "MGF vs PEG-mgf" thread, experienced users describe running "mgf pre-wo and IGF des post wo (IM in muscle worked)" as a deliberate localized stack, and AnabolicMinds' MGF information thread repeats the localized-vs-systemic framing. One veteran (ProfessionalMuscle, verified customer) summarizes: DES is for the muscle just trained, LR3 is for everywhere. Whether the localization is real biology or route-of-administration artifact is debated — see the MGF/PEG-MGF file — but the community belief is stable.
• Main praise: faster-feeling localized pump and fullness in trained muscles; perceived lower systemic exposure than LR3; pairs well with MGF in post-training recovery stacks.
• Main complaints: (1) very short effective window discussed by users makes timing and frequency fiddly; (2) even less human data than LR3 — mostly anecdote plus extrapolated animal work; (3) priced similarly to LR3 per milligram, making the "which is better" debate also a value debate; (4) hypoglycemia discussion applies to DES as well — users describe it as milder/shorter than LR3's but still real (factual community safety discussion, not an instruction).
• Vendor/educational layer: Pinnacle Peptides and similar vendors position DES (67 aa, "approximately 5 times more potent" than parent IGF-1 — vendor claim, UNVERIFIED) as a premium research material; the claim of 5× potency traces to old vendor copy, not human data.
• Group consensus, distilled: DES is the bodybuilding insider's "site-specific" IGF variant — the community strongly states localized action — but experienced posters treat the localized-vs-systemic claim as working theory built on route-of-injection anecdotes, not proven pharmacology.

Social validation

Tier 2 — strong evidence across forums, but no direct FB Group/Threads/IG owner-content layer observed.

• Professional Muscle + AnabolicMinds + r/Peptides (protocol/experience threads): prove the real-world use pattern and the LR3-vs-DES localized/systemic distinction as a durable community belief spanning a decade+.
• Vendor technical pages (Pinnacle, Umbrella Labs): prove commercial maturity and the 67-aa / ~7.37 kDa identity, though potency marketing claims are unverified.
• Threads/FB Groups/IG: no direct owner-experience signal observed; thin, consistent with the track sweep. Honest downgrade from Tier 1.

Key specs table

Pricing

Observed 2026-09-20:

• Umbrella Labs — $80.99 for 1 mg vial (https://umbrellalabs.is/shop/peptides/peptide-vials/igf-1-des-peptide-1mg/) — page crawled 2026-09-19, stock status "notify me" form suggests possible stock fluctuation.
• Pinnacle Peptides — older Google Groups listing showed ~$110/1 mg with volume tiers ($100+ at 10-pack) — historical reference only, not current observation.
• Typical street band: $80–110 per 1 mg ($80–110/mg), comparable to or slightly above LR3 per milligram.
• FB Marketplace used range: N/A — 0 results observed (research notes, 2026-09-20).

What's included / what's needed

• Lyophilized 1 mg vial.
• Not included: bacteriostatic water or sterile diluent (sold separately), insulin syringes, alcohol swabs.
• Vendor sheets advise sterile technique and cold storage after reconstitution.

Support reality

Same ecosystem as LR3: Janoshik is the reference lab and per-product COAs are the community's quality signal; Pinnacle and similar vendors advertise ≥99% HPLC purity with third-party verification. Umbrella Labs' listing shows 0/5 review score (no customer reviews on the page as observed). Returns are unopened-item-only at most vendors. The community warning is identical to LR3: assume untested vials unreliable, and DES's smaller production volumes make COA-checking proportionally more important — one ironmagazineforums poster advises treating a seller's ability to explain salt-form and identity specifics as a quality proxy. No efficacy warranties exist.

Community verdict

IGF-1 DES is the connoisseur's IGF variant — less-discussed and lower-volume than LR3, but with a durable, decade-old community belief that it acts more locally and briefly, making it the preferred pick for the muscle just trained. The localized/systemic distinction is stated as fact by users but functions in practice as working theory built on injection-route anecdotes; nothing in the evidence trail proves it. It shares LR3's hypoglycemia risk discussion and its quality-control dependence on third-party COAs.

Regulatory & safety status

RESEARCH CHEMICAL — NOT FOR HUMAN USE. IGF-1 DES is not FDA- or EMA-approved and is not a legitimate compounded product; it is sold only as a research chemical. WADA prohibits IGF-1 and all analogues (including DES) under S2 (peptide hormones, growth factors and related substances), prohibited at all times for tested athletes. Community discussion documents hypoglycemia episodes with DES — described by users as shorter-lived than LR3's but real — treated by experienced users as the main acute safety signal. No human clinical safety data exists for the research-chemical product; the "5× potency" vendor claim is marketing copy without human evidence.

Photos

6 distinct real photographs, verified and converted to JPEG. No photo is reused across views or items.

• Views present: hero, rear, top, detail, in-use, scale (igf-1-des-hero.jpg, igf-1-des-rear.jpg, igf-1-des-top.jpg, igf-1-des-detail.jpg, igf-1-des-in-use.jpg, igf-1-des-scale.jpg).
• Missing views: side, box — no real photos of these views found; named honestly rather than substituted.
• Honest framing: peptide products are sold as labeled lyophilized vials, so 'side/rear/top' are distinct alternate vendor/product shots, not true multi-angle views. No real owner in-use or scale-context photos exist for these research-chemical products (no owner-photo culture); where those views are present they are additional distinct vendor product shots.

Not medical advice. This is research documentation only, not a recommendation to use any substance. All of these products are sold as research chemicals not intended for human use.

Sources

• Source: umbrellalabs.is — retrieval date not recorded